House of Commons
Inquiry into the adequacy of radiotherapy
EDM #189
Tabled 13 February 2020
2019-21 Session
That this House recognises precision Radiotherapy as a cost effective, life-saving cancer treatment; notes that 1 in 4 people will require access to radiotherapy and that the treatment is crucial in 4 out of every 10 cancer cures; welcomes the Government's commitment to improve early cancer detection but believes the current state of radiotherapy provision is not in a position to cope with increased demand; further notes the shortfalls in radiotherapy delivery highlighted by the APPG for Radiotherapy including an estimated 24,000 patients missing out completely on radiotherapy, excessive treatment travel times, outdated equipment, staff shortages, incoherent commissioning restricting access to treatment and perverse internal tariff system which creates financial disincentives in commissioning the most modern and effective radiotherapy treatment; believes addressing these shortfalls are the route to improving the UK's cancer survival rates which lag behind international comparators; and calls on the Heath and Social Care Select Committee to hold a full inquiry into the current state of radiotherapy services as a matter of priority, add to the weight of evidence, and produce recommendations for the Government in support of increasing access and investment to this life-saving cancer treatment and press for the UK to be a world class centre of excellence for precision advanced radiotherapy.

Signatures (9)

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.
In addition to the sponsors, the following Members have signed to support the motion.
There are no withdrawn signatures for this Motion